These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2905797)

  • 1. The treatment of tranquilizer dependence by propranolol.
    Hallström C; Crouch G; Robson M; Shine P
    Postgrad Med J; 1988; 64 Suppl 2():40-4. PubMed ID: 2905797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
    Hantouche EG; Guelfi JD; Comet D
    Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M; Pashinian A; Weizman R; Fuchs C; Weizman A
    Biol Psychiatry; 2006 Jun; 59(11):1071-7. PubMed ID: 16497273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial.
    Peles E; Hetzroni T; Bar-Hamburger R; Adelson M; Schreiber S
    Addiction; 2007 Dec; 102(12):1947-53. PubMed ID: 17916225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The comparison of tianeptine and carbamazepine in benzodiazepines withdrawal symptoms].
    Kornowski J
    Psychiatr Pol; 2002; 36(6 Suppl):311-8. PubMed ID: 12647454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial.
    Meibach RC; Dunner D; Wilson LG; Ishiki D; Dager SR
    J Clin Psychiatry; 1987 Sep; 48(9):355-8. PubMed ID: 3305488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of benzodiazepine dependence.
    Lennane KJ
    Med J Aust; 1986 May; 144(11):594-7. PubMed ID: 2872582
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dependence on benzodiazepines. Clinical and biological aspects].
    Pelissolo A; Bisserbe JC
    Encephale; 1994; 20(2):147-57. PubMed ID: 7914165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine dependence.
    Khong E; Sim MG; Hulse G
    Aust Fam Physician; 2004 Nov; 33(11):923-6. PubMed ID: 15584332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic benzodiazepine dependence. A comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal.
    Cantopher T; Olivieri S; Cleave N; Edwards JG
    Br J Psychiatry; 1990 Mar; 156():406-11. PubMed ID: 1971767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predicting the success of a benzodiazepine discontinuation programme: myths or clinical wisdom?].
    Knoop H; Kan CC; Mickers FC; Barnhoorn D
    Tijdschr Psychiatr; 2006; 48(9):695-703. PubMed ID: 17007475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trazodone in benzodiazepine dependence.
    Ansseau M; De Roeck J
    J Clin Psychiatry; 1993 May; 54(5):189-91. PubMed ID: 8509349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol and giving up smoking.
    Farebrother MJ; Pearce SJ; Turner P; Appleton DR
    Br J Dis Chest; 1980 Jan; 74(1):95-6. PubMed ID: 6986897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of benzodiazepine dependence.
    Moodley P; Lader M
    S Afr Med J; 1986 Apr; 69(9):563-4. PubMed ID: 3704875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.